InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Lichter Jay, 董事. Director active across 1 company, notably Janux Therapeutics, Inc.. Aggregated, 5 reports have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €38.7m. History available since 13 November 2023. The latest transaction was filed on 13 September 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Jay Lichter is a Director at Janux Therapeutics, Inc., a biotechnology company specializing in the development of targeted therapies. As a director, he participates in the governance of the company and contributes his expertise in the biotechnology field. His role is crucial in guiding the strategic decisions of Janux Therapeutics, Inc.